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Abstract : Necrotizing sialometaplasia is a benign lesion affecting the minor salivary 
glands of the hard palate.  This lesion may be clinically and histopathologically 
confused with malignant lesions.  A case of a 47-year-old man who presented with 
necrotizing sialometaplasia on the left side of the hard palate is herein reported.  
A biopsy was performed, and the condition was diagnosed based on immunohisto-
chemistry.  The lesion receded following treatment with tranexamic acid and sodium 
azulene sulfonate.  The symptom of painful swelling on the hard palate subsided 
within 10 days.  The palatal lesion had disappeared completely 4 months later.
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Introduction
　Necrotizing sialometaplasia is a rare benign lesion of the minor salivary glands commonly 
occurring on the hard palate 1）.  It is histologically characterized by squamous metaplasia of 
the salivary duct and acinar tissues of the minor salivary gland 2）.  This lesion may be confused 
clinically and histopathologically with malignant lesions such as squamous cell carcinoma and 
mucoepidermoid carcinoma.  Here, we report the case of necrotizing sialometaplasia of the hard 
palate treated with tranexamic acid and azulene sulfonate sodium, with an overview of its treat-
ment and pathologic ndings.
Clinical Report
　A 47-year-old man presented to our department with painful swelling on the left side of the 
hard palate （Figure 1）.  One week previously, he was referred to a dentist for the irritative pain 
that was diagnosed as oral stomatitis.  The lesion did not regress following the consumption of 
antibiotics.  He had a habit of smoking more than 20 cigarettes each day and consumed alcohol 
every day.  Clinical examination revealed a lesion on the left side of the hard palate measuring 
25×20 mm, with an ulcer of size 10×5 mm on its posterior region.  His blood analyses revealed 
elevated levels of amylase and salivary-type amylase isoenzyme （Table 1）.  A computed tomog-
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raphy scan showed no signicant bone involvement of the lesion （Figure 2）.  Biopsy of the hard 
palate was performed under local anesthesia.  Histopathological examination showed inltration 
of chronic inammatory cells involving the minor salivary glands associated with focal necrosis 
of the lobules.  Areas of squamous metaplasia of the salivary ducts and acinar tissues were also 
observed （Figure 3）.  There was no denitive evidence of atypical cells in squamous metaplasia 
of the salivary duct cells and acinar cells （Figure 3b）.  Immunohistochemistry showed positive 
staining for calponin （Figure 4a） in the myoepithelial cells, positive staining for Ki-67 （Figure 
4b） and CK-7 （Figure 4c） in the areas of squamous metaplasia of the salivary ducts, and nega-
tive staining for S100 proteins （Figure 4d）, CK-8 （Figure 4e）, and CK-18 （Figure 4f）.  Labeling 
























Fig. 1. Clinical image showing an ulcer on the posterior region of the 
left side of the hard palate
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index of Ki-67 was 9.1％.  p-63 （Figure 4g） was expressed for most parts of the basal cells 
（Figure 4）.  The lesion was conclusively diagnosed as necrotizing sialometaplasia of the hard 
palate.  The patient was treated with 250 mg of tranexamic acid thrice every day and an azulene 
sulfonate sodium gargle.  The lesions tended to shrink, and their paresthesia improved about 10 
days later.  The lesion had resolved completely at the 4-month follow up.  No subsequent recur-
rence was observed until the time of writing this report.
Fig. 2. Computed tomography scan showing a hard palate lesion 
（arrows） without bone involvement （coronal view）
Fig. 3.
（a）  Histological finding of a biopsy specimen showing squamous metaplasia of the salivary ducts 
and acinar tissues （H&E 40× magnification, scale bar 100 µm）．
（b）  No definitive evidence of atypical cells in the squamous metaplasia of the salivary duct cells 
and acinar cells （H&E 200× magnification, scale bar 40 µm）．
Maiko SUZUKI, et al218
Discussion
　Necrotizing sialometaplasia was rst described by Abrams et al in 1973 as a reactive necrotiz-
ing inammatory process 1）.  Clinically, this condition typically manifests as a deep ulcer of the 
hard palate.  Necrotizing sialometaplasia can be divided into the following ve histologic stages: 
infarction, sequestration, ulceration, reparative stage, and healed stage 3）.  Histological features of 
this lesion include ulceration of the overlying epithelium, vascular proliferation, chronic inamma-
tion, and partial necrosis of the minor salivary glands with squamous metaplasia of the salivary 
ducts and acinar tissues 3）.  Necrotizing sialometaplasia is believed to be related to a physico-
chemical or biological injury of the blood vessels that produces ischemic changes.  The latter 
leads to infarction of the minor salivary gland acini with necrosis, inammation, and salivary duct 
metaplasia 4）.  Numerous risk factors have been described to explain the onset of local ischemia 
in the minor salivary glands of the hard palate 5）.  Smokers reportedly have a higher prevalence 
of palatal lesions 6）.  In the present case, the cause was likely to be smoking, and the disease 
was considered to be in the ulceration or reparative stage; however, the direct cause of the 
lesion remains unknown.
　The most important differential diagnoses of necrotizing sialometaplasia include squamous cell 
Fig. 4.
Immunohistochemical analysis showed positive staining for calponin （a） in the myoepithelial 
cells, positive staining for Ki-67 （b） and CK-7 （c） in the areas of squamous metaplasia of the 
salivary ducts, and negative staining for S100 proteins （d）, CK-8 （e）, and CK-18 （f）. P-63 （g） was 
expressed for most of the basal cells. （original magnifications ×100）.
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carcinoma and mucoepidermoid carcinoma 7）.  In some cases, distinguishing necrotizing sialo-
metaplasia from carcinoma may be challenging and require a repeat biopsy.  A supplementary 
diagnosis usuing immunohistochemistry has also been recommended 7）.  The focal presence to 
absence of immunoreactivity for Ki-67 or low immunoreactivity for p53 suggested that the 
lesion was not malignant.  Calponin and p-63 were detected in all stages of the salivary gland, 
preventing needless surgical resection.  Immunohistochemical staining showed that p-63 positivity 
of the residual myoepithelial cells and CK-7 positivity of the metaplastic epithelial islands and 
the salivary ducts can help distinguish necrotizing sialometaplasia from similar conditions such as 
squamous cell carcinoma and mucoepidermoid carcinoma 8）.
　The treatment of necrotizing sialometaplasia does not require surgery 5）.  The treatment of this 
lesion is avoidable due to its tendency for spontaneous healing and depends on whether the 
lesion is symptomatic 7）.  Healing of the lesion is observed within 4-12 weeks.  In the present 
case, the patient was treated with azulene sulfonate and tranexamic acid for inammation con-
trol 6）.  Necrotizing sialometaplasia usually does not recur; when properly diagnosed, it does not 
mandate surgical excision.  Sodium azulene sulfonate is a water-soluble derivative of azulene, an 
anti-inammatory component of chamomile that belongs to the family Asteraceae 9）.  Clinically it 
is used as a therapeutic agent in the treatment of oral stomatitis.  Tranexamic acid is a synthetic 
lysine analog that inhibits brinolysis, promotes clot stability, and reduces inammation 10）.  It 
is likely that tranexamic acid and sodium azulene sulfonate mitigated the healing of the lesion 
more rapidly than in the absence of special therapy.
Conict of interest statement
　The authors have no conflicts of interest to declare.
References
1） Abrams AM, Melrose RJ, Howell FV. Necrotizing sialometaplasia. A disease simulating malignancy. Cancer. 
1973;32:130-135.  
2） Arguelles MT, Viloria Jr BJ, Talens MC, et al. Necrotizing sialometaplasia. Oral Surgery Oral Med Oral Pathol. 
1976;42:86-90.  
3） Shetty A, Chowdappa V, Devasamudra CR, et al. Necrotizing sialometaplasia of the hard palate: a rare entity of 
dilemma on cytology, conrmatory on histopathology. J Clin Diagn Res. 2015;9:ED01-ED02.  
4） Garcia NG, Oliveira DT, Faustino SES, et al. Necrotizing Sialometaplasia of palate: a case report. Case Rep Pathol. 
2012:2012:679325. （accessed 2020 Feb 13） Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432339/pdf/
CRIM.PATHOLOGY2012-679325.pdf
5） Gatti A, Broccardo E, Poglio G, et al. Necrotizing sialometaplasia of the hard palate in a patient treated with 
topical nonsteroidal anti-inammatory drug. Case Rep Dent. 2016:2016:9545861. （accessed 2020 Feb 13） Available 
from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090077/pdf/CRID2016-9545861.pdf
6） Carlson DL. Necrotizing sialometaplasia: a practical approach to the diagnosis. Arch Pathol Lab Med. 2009;133: 
692-698.
7） Yagihara K, Ishii J, Katsurano M, et al. A case of necrotizing sialometaplasia clinically mimicking a malignant 
tumor of the palate. Oral Sci Int. 2018;15:73-77.
Maiko SUZUKI, et al220
8） Kimura Y, Matsuzaka K, Matsuoka K, et al. A case report of necrotizing sialometaplasia with immunohistological 
ndings and a review of the literature. Oral Med Pathol. 2011;15:87-90.
9） Sakai H, Misawa M. Effect of sodium azulene sulfonate on capsaicin-induced pharyngitis in rats. Basic Clin Phar-
macol Toxicol. 2005;96:54-59.
10） Reed MR, Woolley LT. Uses of tranexamic acid. Contin Educ Anaesth Crit Care Pain. 2015;15:32-37.
［Received February 17, 2020 : Accepted March 23, 2020］ 
